Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Sanofi
organization21 mentionslast seen Nov 11, 2026
Pharmaceutical company where R. Duane Clark II serves as General Manager, U.S. Rare Diseases.
Relationships 16
- SanofiownsAmunix Pharmaceuticals, Inc.99% confidence2 sources
- SPARETECHsuppliesSanofi99% confidence2 sources
- SanofidevelopsModulus95% confidence1 source
- Sanofifunded bySanofi upfront payment94% confidence1 source
- Regeneron Pharmaceuticals, Inc.partners withSanofi94% confidence1 source
- Recursion Pharmaceuticals, Inc.partners withSanofi93% confidence1 source
- SanoficommercializesNEXVIAZYME90% confidence1 source
- SanoficommercializesLUMIZYME90% confidence1 source
- SanofiemploysR. Duane Clark II90% confidence1 source
- Sanofipartners withNurix Therapeutics, Inc.90% confidence1 source
- Sanofidevelopsinflammatory disease treatment85% confidence1 source
- SanofiemploysJochen Maas85% confidence1 source
- SanofidevelopsSAR44827285% confidence1 source
- Oxford Biomedicapartners withSanofi80% confidence1 source
- Sanofipartners withVeeva Systems70% confidence1 source
- Sanofiinvests inRecursion Pharmaceuticals, Inc.60% confidence1 source
Relationship
Sanofifunded bySanofi upfront payment
94% confidence1 supporting mentionsfrom Oct 1, 2026
Either name opens that entity’s relationships.
Sources 1